Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Spark Biomedical wins FDA breakthrough nod for newborn opioid withdrawal relief device

December 16, 2020 By Nancy Crotti

The Roo system (Image courtesy of Spark Biomedical)

Spark Biomedical announced today that the FDA granted breakthrough device designation to its transcutaneous electrical nerve stimulator designed to reduce signs and symptoms of neonatal opioid withdrawal syndrome (NOWS).

NOWS results from exposure to prescription or non-prescription opioids such as methadone or heroin during pregnancy. Currently, no nationwide standard of care exists for managing NOWS, although oral morphine weaning for a national average of 21 days is common practice.

The Roo system is a non-invasive neurostimulation device based on the company’s adult device, the Sparrow therapy system. Intended to be applied by healthcare professionals in a neonatal intensive care unit, the system is designed to promote the release of endogenous opioids (endorphins), supplanting the need for oral morphine. The endorphin release is achieved by safely activating nerve branches on and around the ear of newborn infants, according to the Dallas, Texas-based company.

In tandem with its FDA breakthrough submission, Spark began an NIH/NIDA-funded clinical study with the Medical University of South Carolina to assess the safety and effectiveness of the Roo System in neonates as an adjunctive therapy to the use of oral morphine. The data from this clinical study, used to support the FDA’s breakthrough decision, demonstrated that the Roo System can significantly reduce the duration of oral morphine use to less than ten days with no adverse events, according to the company.

“We know that an increase in opioid misuse can have a direct connection to a rise in NOWS cases,” said Spark Biomedical CEO Daniel Powell in a news release. “We submitted the Roo system for breakthrough device designation because we see a growing need and we’re dedicated to getting this solution to the most vulnerable of patients as quickly as possible.”

“It is heartbreaking to see babies go through withdrawal,” added Spark’s chief technology officer, Alejandro Covalin. “It is a privilege to have this opportunity to develop technology to help these babies overcome NOWS and minimize the potentially lifelong consequences of current treatments. Breakthrough device designation is evidence of the need for this therapy and will help us expedite the delivery of a life-changing technology to those in dire need.”

Related Articles Read More >

A cylindrical-shaped medical device with a blue cap on one end and a brown cap on the other
How SeaStar’s device calms hyperinflammation — and could prevent lasting damage from COVID cytokine storms
A phlebotomist draws blood from a patient in her home
How to leverage technology to drive diversity in clinical studies
A portrait of Finnegan attorney Marcelo Barros
Medical device licensing pitfalls to avoid
Miniature device components next to a dime coin for scale
Tolerance stack-up: Insight into the inner workings of high-density microelectronic medical devices

DeviceTalks Weekly.

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech